HSH PF
Hillshire Brands–Pilgrim's Pride proposed an acquisition of Hillshire for $45 per share in cash or $6.4 billion. That comes just two weeks after Hillshire announced a $4.3 billion cash-and-stock deal to buy Pinnacle Foods.
AZN PFE
AstraZeneca—Pfizer said it would not make a formal offer to buy its rival drug maker. AstraZeneca had said that Pfizer's most recent informal bid still undervalued the company.
DRTX
Shares of Durata Therapeutics are off 23% premarket on modest volume in apparent profit-taking after the pre-Dalvance approval run-up over the past 30 days when shares popped ~45% from the April 14 low of $11.68.
New day high in the last 30 minutes.
HD
YOKU
ISIS
SINA
DWRE
Penny stock
BCRX
Interest
PPC
ARUN
PANW
SPLK
GTAT
Данная публикация является личным мнением автора. Мнение владельца сайта может не совпадать с мнением автора.
Пользователь запретил комментарии к топику.